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Proteomics and C9orf72 neuropathology identify
ribosomes as poly-GR/PR interactors driving toxicity
Hannelore Hartmann1,*, Daniel Hornburg2,* , Mareike Czuppa1, Jakob Bader2 , Meike Michaelsen1, Daniel Farny1,
Thomas Arzberger1,3,4, Matthias Mann2,4, Felix Meissner2, Dieter Edbauer1,5,6
Frontotemporal dementia and amyotrophic lateral sclerosis
patients with C9orf72mutation show cytoplasmic poly-GR and poly-
PR aggregates. Short poly-(Gly-Arg) and poly-(Pro-Arg) (poly-GR/PR)
repeats localizing to the nucleolus are toxic in various model
systems, but no interactors have been validated in patients. Here,
the neuronal interactomes of cytoplasmic GFP-(GR)149 and nucleolar
(PR)175-GFP revealed overlapping RNA-binding proteins, including
components of stress granules, nucleoli, and ribosomes. Over-
expressing the poly-GR/PR interactors STAU1/2 and YBX1 caused
cytoplasmic aggregation of poly-GR/PR in large stress granule–like
structures, whereas NPM1 recruited poly-GR into the nucleolus.
Poly-PR expression reduced ribosome levels and translation con-
sistent with reduction of synaptic proteins detected by proteomics.
Surprisingly, truncated GFP-(GR)53, but not GFP-(GR)149, localized to
the nucleolus and reduced ribosome levels and translation similar
to poly-PR, suggesting that impaired ribosome biogenesis may be
driving the acute toxicity observed in vitro. In patients, only ribo-
somes and STAU2 co-aggregated with poly-GR/PR. Partial se-
questration of ribosomesmay chronically impair protein synthesis
even in the absence of nucleolar localization and contribute to
pathogenesis.
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Introduction
Since the discovery of the (GGGGCC)n repeat expansion in C9orf72
in about 10% of amyotrophic lateral sclerosis (ALS) and fronto-
temporal dementia patients, several potential pathomechanisms
have been proposed (Edbauer & Haass, 2016). The repeat RNA is
clustered in nuclear foci in neurons and non-neuronal tissues in
patients, without apparent correlation with neuron loss (DeJesus-
Hernandez et al, 2017). Several proteins binding to the repeat RNA
have been identiﬁed, but up to now their role in pathogenesis is still
unclear. Furthermore, sense and antisense transcripts of the repeat
are translated into ﬁve dipeptide repeat (DPR) proteins that co-
aggregate in predominantly neuronal cytoplasmic inclusions in
C9orf72 patients: poly-GA, poly-GP, poly-GR, poly-PR, and poly-PA.
Although several groups failed to detect a direct correlation of DPR
expression with neurodegeneration (Mackenzie et al, 2013, 2015;
Schludi et al, 2015), a recent report identiﬁed dendritic poly-GR
pathology speciﬁcally in the motor cortex of ALS patients (Saberi
et al, 2018), although it is unclear how the conﬂicting ﬁndings can be
explained. Therefore, the role of the DPR proteins in disease
pathogenesis is still under intense debate.
Individual expression of poly-(Gly-Arg) and poly-(Pro-Arg) (poly-
GR/PR) is highly toxic in various model systems (Kwon et al, 2014;
Mizielinska et al, 2014; Wen et al, 2014; Jovicic et al, 2015; Boeynaems
et al, 2016; Lee et al, 2016; Lin et al, 2016; Lopez-Gonzalez et al, 2016),
but poly-GR and especially poly-PR show predominantly nucleolar
localization in most in vitro systems, which is not observed in
patient tissue (Schludi et al, 2015). Genetic screens for poly-PR
toxicity have highlighted a link to nucleocytoplasmic transport
(Jovicic et al, 2015; Boeynaems et al, 2016), whereas poly-GR seems
to predominantly affect other pathways in yeast (Chai & Gitler,
2018). Recently, poly-GR/PR have been shown to undergo phase
separation in vitro and interact with low-complexity domain pro-
teins in membrane-less organelles, speciﬁcally in the nucleolus
and stress granules (Lee et al, 2016; Lin et al, 2016; Boeynaems et al,
2017). Poly-GR/PR–interacting proteins have been analyzed using
pull-down experiments with short peptides that spontaneously
phase-separate together with proteins and RNA from the cell ex-
tracts (Kanekura et al, 2016; Lin et al, 2016; Boeynaems et al, 2017; Yin
et al, 2017) or using expression of short repeat constructs (Lee et al,
2016; Lopez-Gonzalez et al, 2016). In contrast to several poly-GA–
interacting proteins (May et al, 2014; Zhang et al, 2016; Schludi et al,
2017), none of the reported poly-GR/PR interactors has been val-
idated in patient tissue. Poly-GR/PR toxicity has also been linked to
altered splicing (Kwon et al, 2014; Yin et al, 2017), reduced trans-
lation (Kanekura et al, 2016), ER stress (Kramer et al, 2018), and
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mitochondrial stress (Lopez-Gonzalez et al, 2016), but it is unclear
which effects are relevant in patients. The severe toxicity in some
model systems is hard to reconcile with the prodromal expression at
least of poly-GR many years before disease onset (Vatsavayai et al,
2016). Therefore, current models likely exaggerate toxicity although it
is possible that cytoplasmic poly-GR/PR inclusions trigger similar
pathways in vivo with milder effects.
To elucidate the functional consequences of poly-GR/PR ex-
pression in patients, we analyzed the interactomes of poly-GR and
poly-PR in primary neurons and HEK293 cells and validated can-
didate proteins in cellular systems and patient tissue, focusing
on stress granules, the nucleolus, and ribosomes. Overexpression
of several interactors recruits poly-GR/PR into large cytoplasmic
stress granule–like structures. Moreover, acute neurotoxicity of
poly-GR/PR requires nucleolar localization and is associated with
reduced levels of ribosomes and impaired translation. Importantly,
we could validate co-aggregation of ribosomes in cytosolic DPR
inclusions in patient brain tissue, supporting a primary role of
translational inhibition for poly-GR/PR toxicity in vivo.
Results
Poly-GR and poly-PR interact with ribosomes, stress granules,
and low-complexity proteins
To identify which poly-GR and poly-PR interactors would be most
relevant for neurodegeneration in C9orf72 patients, we analyzed the
poly-GR/PR interactomes in rat primary cortical neurons and
HEK293 cells. Consistent with previous results (Schludi et al, 2015),
lentiviral expression with GFP-(GR)149 in neurons resulted in pre-
dominantly diffuse cytoplasmic expression and some nucleolar
localization, whereas (PR)175-GFP was mostly localized to the nu-
cleolus (Fig S1A and B). Fusion with nuclear export signals or (GA)50
failed to shift poly-PR quantitatively to the cytoplasm (data not
shown). In HEK293 cells, (PR)175-GFP also mainly localized to the
nucleolus, whereas GFP-GFP-(GR)149 was found in both nucleolus
and cytoplasm. In contrast to previous reports, only (PR)175-GFP, but
not GFP-(GR)149, induced signiﬁcant cell death in neurons com-
pared with the GFP control as measured by an LDH release assay
(Fig S1C). However, both (PR)175-GFP and GFP-(GR)149 impaired the
growth of HEK293 cells as shown by the XTT assay, which measures
mitochondrial activity (Fig S1D) but did not trigger signiﬁcant cell
death as reported previously (May et al, 2014). Overall, these ob-
servations suggest that nucleolar localization may be important for
poly-GR/PR toxicity in vitro.
For the interactome analysis from primary neurons and HEK293
cells, we immunoprecipitated GFP-(GR)149, (PR)175-GFP, and a GFP
control using GFP antibodies and analyzed the interactome using
quantitative mass spectrometry. In primary neurons, we quanti-
tatively compared close to 600 proteins (Table S1A). Among those,
we identiﬁed 89 poly-GR and 104 poly-PR interactors (Fig S2A), of
which ~60% are annotated as RNA-binding proteins (Gerstberger
et al, 2014). Both DPR proteins interact with numerous components
of ribosomes, the nucleolus, and stress granules (Jain et al, 2016) as
well as proteins involved in splicing. 39 proteins were commonly
enriched in both interactomes (Fig 1A). Consistent with previous
data, sequence analysis of poly-GR/PR interactors shows enrich-
ment of proteins with low-complexity domains (Fig 1B).
For comparison, we additionally analyzed the poly-GR/PR inter-
actome from HEK293 cells, resulting in 394 proteins enriched ex-
clusively in poly-GR and 49 proteins enriched in both poly-GR and
poly-PR (Fig S2B and Table S1B). Only one protein (CD2AP) was solely
enriched in the poly-PR interactome. In total, about 80% of the
interactors are annotated as RNA-binding proteins (Gerstberger et al,
2014). Overall, there was a consistent overlap with published data
(Lee et al, 2016; Lin et al, 2016; Boeynaems et al, 2017).
Comparison of the gene ontology (GO) terms enriched in the
poly-GR/PR interactors in primary neurons and HEK293 cells showed
a strong selectivity for proteins related to ribosomes, stress granules,
the nucleolus, the spliceosome, and the methylosome (mediating
arginine methylation) in the poly-GR interactome (Fig 1B and Table
S2). Interaction of PRMT1/5 with poly-GR, but not poly-PR, suggests
that only poly-GR is arginine methylated (Schludi et al, 2015). Poly-
PR interactors were most strongly enriched in proteins of the U1
and U4 small nuclear RNP, the exon–exon junction complex and
mitochondrial ribosomes in both cell types. Although several cy-
tosolic ribosomal proteins were enriched in the (PR)175-GFP im-
munoprecipitates in neurons (Fig S2A), several other subunits were
depleted, which may be explained by the overall reduction of cy-
tosolic ribosomal proteins in poly-PR–expressing neurons, whereas
mitochondrial ribosomal proteins are even found at higher levels
(Figs 5B and S6B).
In summary, poly-GR/PR interact preferentially with RNA-binding
proteins. For the functional analysis, we focused on the interaction of
poly-GR/PR with the nucleolus, stress granules, and the ribosome
and compared ﬁndings from overexpression of several interactors in
cultured cells with patient tissue.
NPM1 traps poly-GR into the nucleolus
To functionally validate putative poly-GR/PR–interacting proteins
and get a better understanding of their role in DPR toxicity, we
co-expressed RFP-tagged interactors together with GFP-(GR)149,
(PR)175-GFP, or control GFP in HEK293 cells and neurons and analyzed
the localization of the DPR proteins and the interacting proteins.
First, we tested the nucleolar proteins NOP56 and NPM1, which
we identiﬁed as interactors in both cell types (Fig 1A and Table S1).
As expected, RFP-NOP56 and RFP-NPM1 co-localized with poly-GR
and poly-PR predominantly in the nucleolus in HEK293 cells (Fig S3).
In primary neurons, GFP-(GR)149 was largely absent from the nu-
cleolus (Fig 2A). However, expression of RFP-NPM1 surprisingly
recruited cytoplasmic GFP-(GR)149 into the nucleolus resulting in
co-localization in almost all cells (Fig 2B and D). In contrast, poly-GR
localized predominantly to the cytosol in RFP-NOP56–transduced
neurons, similar to the RFP control (Fig 2A, C, and D). Poly-PR co-
localized with RFP-NOP56, but co-expression altered the distri-
bution of RFP-NOP56 within the nucleolus compared with GFP or
GFP-(GR)149 (Fig 2C, close-up in right column). Although RFP-NOP56
is evenly distributed in the nucleolus under control conditions in
neurons, it showed a granular pattern in poly-PR–expressing cells,
which is consistent with the poly-PR–speciﬁc interaction of NOP56
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in neurons (Fig 1A). Thus, the interaction of poly-GR/PR with nu-
cleolar proteins has sufﬁcient afﬁnity to alter the subcellular
distribution of either binding partner.
STAU1/2 and YBX1 reroute poly-GR/PR into large cytoplasmic
granules
The poly-GR/PR interactomes contain many stress granule–related
proteins, but only a small fraction of transfected cells shows small
cytoplasmic poly-GR/PR granules (arrows in Fig S3A). However,
expression of several RNA-binding proteins from the poly-GR/PR
interactome promoted cytoplasmic clustering of the two DPR
protein species in HEK293 cells. Most strikingly, STAU1/2 and YBX1
rerouted both poly-GR and poly-PR into cytoplasmic clusters that
can be quite large (Fig 3A) and are reminiscent of the cytoplas-
mic poly-GR/PR inclusions seen in patients (Mori et al, 2013a, b).
In contrast, we did not detect any differences with the stress
granule–associated poly-PR interactor EIF4A3 (Fig 3A and B).
Quantitative analysis showed that the average size and also the
number of cytoplasmic poly-GR/PR inclusions are strongly in-
creased upon expression of RFP-STAU1/2 and RFP-YBX1 but not
RFP-EIF4A3 (Fig 3B).
Using transient co-transfection to allow higher expression levels
in primary neurons, we detected similar co-localization of GFP-(GR)149
with RFP-STAU1/2 and RFP-YBX1 in cytoplasmic clusters (Fig 3C) but
not for RFP-EIF4A3 (datanot shown). Presumably becauseof evenhigher
toxicity, we did not detect (PR)175-GFP–expressing neurons upon trans-
fection. Thus, the interaction with several stress granule–associated
proteins recruits poly-GR/PR into large cytoplasmic granules resem-
bling the neuronal cytoplasmic inclusions seen in C9orf72 patients.
Cytoplasmic poly-GR/PR clusters resemble stress granules
To elucidate the nature of these cytoplasmic poly-GR/PR clusters,
we probed HEK293 cells co-transfected with RFP-STAU1 and poly-
GR/PR with the stress granule marker G3BP1 and detected striking
co-localization and sequestration of G3BP1 into the poly-GR/PR
granules (Fig 4A). Without co-expression of RNA-binding proteins,
Figure 1. Poly-GR and poly-PR interact with similar
low-complexity proteins in neurons.
Quantitative proteomics of GFP immunoprecipitations
from primary cortical neurons transduced with GFP,
GFP-(GR)149, or (PR)175-GFP (DIV7 + 8). The complete
dataset is available in Table S1. (A) Proteins with
signiﬁcant enrichment in poly-GR/PR interactomes
compared with GFP control were manually grouped into
functional categories. Orthologues of proteins in italics
were also found in the poly-GR/PR interactomes from
HEK293 cells. Underlined proteins are analyzed in this
paper. (B) Proportion of low-complexity regions
(IUPred-L) of all proteins identiﬁed in the neuronal
interactome analysis, the poly-GR interactome, and the
poly-GR interactome. Signiﬁcance of difference was
assessed with the Mann–Whitney–Wilcoxon test, exact
P-values: GFP versus GFP-(GR)149, P = 0.004566 and GFP
versus (PR)175-GFP, P = 0.001656. Whiskers extend to ±1.5
box height (i.e., total three times the interquartile
range). (C) 2D analysis of GO enrichment terms (GOMF,
GOCC, GOCC, GOPB, KEGG, and UniProt keywords) and
stress granule proteins (Jain et al, 2016) for proteins
found in the poly-GR and poly-PR interactome in
primary neurons and HEK293 cells (Fig S2 and Tables S1
and S2). Some dots with nearly identical position and
annotation were removed for clarity. Related terms from
the main enriched pathways are labeled in the same
color. Annotation terms with a Benjamini–Hochberg FDR
(q-value) <0.1 and comprising at least six proteins
quantiﬁed by mass spectrometry are shown. 1D
annotation scores close to 1 indicate strongest
enrichment over the GFP control, scores close to
0 indicate no enrichment, and scores close to –1
indicate strongest depletion. The analysis was
performed in Perseus software (Tyanova et al, 2016).
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the less frequent cytoplasmic poly-GR/PR punctae were predom-
inantly G3BP1 positive, indicating that overexpression of STAU1/2
and YBX1 enhances a normal process that may ultimately lead to
aggregation of poly-GR/PR in patients (compare Fig 3B), which is
consistent with the interaction with stress granule proteins under
basal conditions (Fig 1).
Then, we wondered whether poly-GR/PR inclusions in patients
could be labeled by stress granule markers and compared an fron-
totemporal lobar degeneration case with C9orf72 repeat expansion
with a healthy control case by double immunoﬂuorescence. As ex-
pected, the C9orf72 frontotemporal lobar degeneration case showed
widespread poly-GR and sparse poly-PR cytoplasmic inclusions in the
frontal cortex. We detected not a single poly-GR/PR inclusion con-
vincingly co-localizing with classical stress granule markers proteins
(G3BP2 and TIAR) and the interactor YBX1 in two C9orf72 patients.
However, ~25 % of poly-GR inclusions (76 of 300 counted aggregates)
were co-stained with STAU2 in cortex (Fig 4B).
In conclusion, despite interaction of poly-GR/PR with many
stress granule–related proteins and recruitment of poly-GR/PR
into stress granules on overexpression of STAU1/2 and YBX1,
classical stress granule marker proteins are not readily detectable
in the poly-GR inclusions in postmortem brains of C9orf72 patients,
suggesting a more transient interaction.
Poly-GR/PR inclusions in patients contain ribosomes
Because the ribosomal proteins are very prominent in the poly-GR/PR
interactomes, we additionally analyzed the localization of the 40S
protein RPS6 in poly-GR/STAU1–co-transfected HEK293 cells (Fig
S4A). Unlike for stress granule markers, we detected only modest
amounts of RPS6 in poly-GR/PR inclusions without strong en-
richment compared with the cytoplasm.
We did not analyze individual ribosomal proteins using the co-
expression approach because tagging the ribosome is notoriously
difﬁcult. Instead, we directly analyzed the localization of several
ribosomal proteins with good available antibodies directly in patient
brain. Compared with controls, several ribosomal subunits (RPS6, RPS25,
RPL19, and RPL36A) were enriched in both poly-GR and, less strikingly,
also in poly-PR inclusions (Figs 5A and S4B). Quantiﬁcation shows that
approximately one third of GR inclusions show co-localization with
ribosomal proteins in cortex (Figs 5B and S4C). However, most neurons
showed robust residual ribosome staining in the cytoplasm.
Moreover, we extensively tested co-aggregation of poly-GR/PR
with other interactors identiﬁed in vitro. From 22 tested proteins, six
showed convincing staining of endogenous proteins, but we could
not detect co-localization with poly-GR in C9orf72 patients (Fig S5A;
see the Materials and Methods section).
Thus, among the tested poly-GR/PR–interacting proteins, STAU2
and the cytosolic ribosome seems to be the most relevant co-
aggregating protein (complex) in C9orf72 patients.
Poly-PR reduces cytosolic ribosome levels and inhibits overall
translation
Given the wide-spread interaction of poly-GR/PR with ribosomes
and other RNA-binding proteins, we also analyzed global protein
Figure 2. NPM1 drives poly-GR into the nucleolus of
primary neurons.
Primary rat neurons (DIV7 + 7) were cotransduced with
RFP-tagged nucleolar interactors NPM1 and NOP56 with
GFP, GFP-(GR)149, or (PR)175-GFP. (A–C) Single focal
planes obtained by confocal microscopy are shown.
DAPI was used as nuclear marker and the scale bar
depicts 20 μm. RFP was used as negative control. Left
columns show GFP signal, middle columns show RFP-
tagged proteins, and right columns show merge of GFP,
RFP-tagged proteins, and nuclear DAPI staining (blue).
RFP-NPM1 and RFP-NOP56 are co-localizing with poly-
PR. Note that NPM1 expression recruits poly-GR into the
nucleolus (red arrow). Poly-PR–expressing neurons
show altered NOP56 nucleolar staining (single channel
shown in zoom). (D) Fraction of cells with poly-GR
localized to the nucleolus in NPM1– andNOP56–expressing
neurons compared with the RFP control (RFP, n = 9; RFP-
NPM1, n = 11; andRFP-NOP56, n = 10 images (40× objective)
from three independent experiments, mean ± SEM, exact
P-values: RFP versus RFP-NPM1, P = 0.0001 and RFP versus
RFP-NOP56, P = 0.2307 in one-way ANOVA with Dunnett’s
posttest).
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expression using quantitative LC-MS/MS in poly-GR/PR–transduced
primary neurons. GFP-(GR)149 transduction had no overt effect on the
neuronal proteome and expression levels of none of its interactors
were signiﬁcantly altered (Fig S6A, red dots). Strikingly, (PR)175-GFP
expression signiﬁcantly affected expression of hundreds of proteins
comparedwith the GFP control. These changesweremuch larger than
mRNA expression changes reported recently (Kramer et al, 2018),
supporting a primary effect of poly-PR on translation. These ﬁndings
are consistent with the selective toxicity of (PR)175-GFP compared with
GFP-(GR)149 observed in our culture system (Fig S1C). GO annotation
analysis revealed overall reduction of cytosolic ribosomal proteins,
whichmay explain the strong down-regulation of synaptic and axonal
proteins (Fig S6B). In contrast, the levels of nucleolar and mito-
chondrial proteins were slightly increased. Overall, stress granule
proteins (Fig S6B) and poly-GR/PR interactors (Fig S6A) were not
affected. Despite the few large individual changes in the proteome of
poly-GR–expressing cells, enrichment analysis shows a small but
signiﬁcant overall reduction of ribosomal proteins (Fig S6B), which is
consistent with the interaction of poly-GR with ribosomal proteins in
cellular models and patient brains (Figs 1 and 5).
To substantiate this ﬁnding, we analyzed ribosomal protein
expression in poly-PR/GR–expressing neurons by immunoblotting.
Lentiviral poly-PR expression in primary neurons signiﬁcantly re-
duced expression of ribosomal subunits RPS6, RPL19, and RPL36A,
whereas cytoplasmic poly-GR expression had no strong effect (Fig
6A and B), despite the ﬁnding of subtle reduction by proteomics (Fig
S6B). To investigate whether this loss of ribosomal components had
an effect on total protein synthesis, we performed a surface sensing
of translation (SUnSET) assay, which measures puromycin in-
corporation into newly synthesized proteins. After a brief pulse with
puromycin, robust puromycin incorporation could be detected by
immunoblotting with a puromycin-speciﬁc antibody. Importantly,
Figure 3. STAU1/2 and YBX1 recruit poly-GR/PR into
large cytoplasmic granules.
HEK293 cells and primary cortical neurons
were co-transfected with GFP, GFP-(GR)149, or
(PR)175-GFP expression vectors and RFP-tagged
interactors associated with stress granules.
(A) Immunoﬂuorescence images of HEK293 cells
showing co-expression of RFP-STAU1/2, RFP-YBX1, or
RFP-EIF4A3 together with GFP-(GR)149, (PR)175-GFP, or
GFP. STAU1/2 and YBX1 reroute poly-GR and poly-PR
into large cytoplasmic structures (white arrows).
Left columns show GFP signal, right columns show
merge of GFP, RFP-tagged proteins, and nuclear
DAPI staining (blue). Scale bar denotes 20 μm.
(B) Quantiﬁcations of cytoplasmic poly-GR/PR granules
from (A). Left bar graph shows percentage of
cytoplasmic granules out of all granules (in nucleolus
and cytoplasm) in poly-GR (red bars) and poly-PR
(blue bars) (GR/RFP, n = 16 images (40×) from
two independent experiments: PR/RFP, n = 14;
GR/RFP-STAU1, n = 19; PR/RFP-STAU1, n = 20; GR/RFP-
STAU2, n = 10; PR/RFP-STAU2, n = 8; GR/RFP-YBX1, n = 14;
PR/RFP-YBX1, n = 14; GR/RFP-EIF4A3, n = 6; and
PR/RFP-EIF4A3, n = 6). Cytoplasmic granule size is
represented by the right bar graph (GR/RFP, n = 130
aggregates from two individual experiments; PR/RFP,
n = 132; GR/RFP-STAU1, n = 104; PR/RFP-STAU1, n = 132;
GR/RFP-STAU2, n = 123; PR/RFP-STAU2, n = 65; GR/RFP-
YBX1, n = 119; PR/RFP-YBX1, n = 53; GR/RFP-EIF4A3, n = 93;
and PR/RFP-EIF4A3, n = 71). Mean ± SEM is shown,
exact P-values for left graph: GR/RFP-STAU1 versus
GR/RFP, P = 0.0001; GR/RFP-STAU2 versus GR/RFP,
P = 0.0001; GR/RFP-YBX1 versus GR/RFP, P = 0.0001;
GR/RFP-EIF4A3 versus GR/RFP, P = 0.0775; PR/RFP-STAU1
versus PR/RFP, P = 0.9999; PR/RFP-STAU2 versus PR/RFP,
P = 0.0007; PR/RFP-YBX1 versus PR/GFP, P = 0.7820; PR/
RFP-EIF4A3 versus PR/RFP, P = 0.3936; exact P-values for
right graph: GR/RFP-STAU1 versus GR/RFP, P = 0.0001;
GR/RFP-STAU2 versus GR/RFP, P = 0.0001; GR/RFP-YBX1
versus GR/RFP, P = 0.0023; GR/RFP-EIF4A3 versus GR/
RFP, P = 0.9672; PR/RFP-STAU1 versus PR/RFP, P = 0.0001;
PR/RFP-STAU2 versus PR/RFP, P = 0.0001; PR/RFP-YBX1
versus PR/RFP, P = 0.0023; and PR/RFP-EIF4A3 versus
PR/RFP, P = 0.8492 in one-way ANOVA with Dunnett’s
posttest. (C) Immunoﬂuorescence images of transfected
neurons (DIV7 + 3) co-expressing RFP-STAU1, RFP-STAU2,
or RFP-YBX1, and GFP-(GR)149 or GFP obtained by
confocal microscopy are shown. Top row shows GFP
signal, middle row shows RFP-tagged interactor or RFP
control, and bottom row shows merge including nuclear DAPI (blue). Comparison of the largely homogenous poly-GR pattern in the RFP with punctate distribution in
neurons co-expressing RFP-STAU1/2 and YBX1.
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the poly-PR–induced loss of ribosomal subunits was accompanied
by a comparable reduction in overall protein synthesis compared
with the GFP control, suggesting that the reduction of individual
ribosomal subunits reﬂects a loss of functional ribosomes (Fig 6C
and D).
Thus, poly-PR and to a lesser extent GFP-(GR)149 expression leads
to an overall reduction of cytosolic ribosomes, which results in
a signiﬁcant reduction of overall translation on poly-PR expression.
Nucleolar poly-GR expression impairs translation and nucleolar
structure and enhances toxicity
Numerous groups have reported poly-GR toxicity in various model
systems, including primary neurons (Wen et al, 2014); these reports
mostly used constructs with 20–100 repeats and typically involved
predominantly nucleolar poly-GR localization, like we had observed
in HEK293 cells, where we noticed slowed growth comparable with
(PR)175-GFP–expressing cells (Fig S1). Thus, we asked whether lack of
nucleolar localization for GFP-(GR)149 in primary neurons despite
a signiﬁcant overlap of interacting proteins with (PR)175-GFP might
explain these discrepancies. Therefore, we truncated our GFP-(GR)149
construct resulting in GFP-(GR)53 and then analyzed its localization
in primary neurons. GFP-(GR)53 showed diffuse cytoplasmic local-
ization and strong localization in the nucleolus of 77.5% of the
transduced neurons (Fig 7A). GFP-(GR)53 also induced neuronal
death compared with GFP control, although less effectively than
(PR)175-GFP (Fig 7B).
Moreover, lentiviral GFP-(GR)53 expression also signiﬁcantly re-
duced the expression of the ribosomal subunit RPS6 and protein
synthesis similar to (PR)175-GFP, whereas GFP-(GR)149 had no effect,
suggesting that nucleolar poly-GR/PR expression interferes with
ribosomal biogenesis resulting in impaired translation and poly-
GR/PR in vitro toxicity (Fig 7C and E). Because acute GFP-(GR)53
toxicity is still weaker than poly-PR toxicity, we additionally ana-
lyzed nucleolus organization using immunoﬂuorescence of ﬁbril-
larin (Fig 7A and D). In GFP-(GR)149– and GFP–expressing neurons,
most nucleoli showed homogenous staining of ﬁbrillarin. In contrast,
GFP-(GR)53 expression led to a ring-like ﬁbrillarin distribution and
occasionally to a granular pattern, which was evenmore pronounced
in (PR)175-GFP–expressing neurons. Thus, nucleolar localization may
promote the acute toxicity of poly-GR/PR seen in vitro.
Discussion
We analyzed poly-GR/PR interactors in primary neurons and
C9orf72 brains to address the disconnect between acute toxicity in
various model systems and prodromal expression decades before
clinical symptoms in patients. In primary neurons, poly-GR and
poly-PR interact with RNA-binding proteins, including many com-
ponents of the nucleolus, stress granules, and the ribosome. Over-
expression of the interactors NPM1 and STAU1/2 reroutes poly-GR
into the nucleolus or large stress granule–like structures in vitro,
respectively. Poly-GR/PR toxicity in vitro depends on nucleolar lo-
calization and structural alterations of the nucleolus. Direct binding
of ribosomes and/or impaired ribosomal biogenesis in the nucleolus
likely contributes to impaired translation. Importantly, we detected
ribosomal proteins in the pathognomonic neuronal cytosolic poly-
GR/PR inclusions in C9orf72 patients, suggesting that milder effects
on translation may drive the slower neurodegeneration seen in
patients.
Poly-GR/PR interactome
We analyzed the interactome of poly-GR/PR in transduced rat
cortical neurons and transfected HEK293 cells using GFP-(GR)149
Figure 4. Cytoplasmic poly-GR/PR inclusions
resemble stress granules in vitro.
Immunoﬂuorescence of stress granule markers in
HEK293 cells and patient brain. DAPI visualizes nuclei.
Single confocal planes were taken. Scale bar depicts
20 μm. (A) Co-localization of poly-GR/PR with the stress
granule marker G3BP1 in HEK293 cells co-transfected
with RFP-STAU1 or RFP control and DPR-GFP or GFP
control. Left three columns show individual channels as
indicated. The fourth columns show merge with
additional nuclear DAPI staining in white. Arrows
indicate cytoplasmic inclusions co-labeled with G3BP1.
(B) Immunoﬂuorescence of frontal cortex of a C9orf72
patient and a healthy control case to analyze co-
localization of poly-GR with stress granule components
TIAR, G3BP2, YBX1, and STAU2. Arrows indicate poly-GR
aggregates.
Source data are available for this ﬁgure.
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and (PR)175-GFP baits. The repeat length of our constructs is still
shorter than the repeats seen in patients but signiﬁcantly longer
than in previous studies using mainly pull-down with 20-mer or 30-
mer peptides (Kanekura et al, 2016; Lin et al, 2016; Boeynaems et al,
2017; Yin et al, 2017) or recombinant expression of (GR)50, (GR)80, and
(PR)50 in cell lines (Lee et al, 2016; Lopez-Gonzalez et al, 2016).
Moreover, the predominant cytoplasmic localization of GFP-(GR)149
more accurately reﬂects the patient situation. Similar to the peptide-
based studies, we identiﬁed a large number of RNA-binding proteins,
in particular components of the cytosolic and mitochondrial ribo-
some, stress granules, the nucleolus, and (especially in poly-PR)
splicing factors. A large fraction of proteins contains low-complexity
domains associated with phase separation properties (Lee et al,
2016; Lin et al, 2016; Boeynaems et al, 2017).
It is striking that GFP-(GR)149 and (PR)175-GFP constructs interacted
mostly with overlapping proteins but showed dramatically different
toxicity in LDH release assays and effects on proteome composition.
Quantitative comparison of the poly-GR and poly-PR interactomes is
confounded by the different localization of poly-GR in HEK293 cells
and primary neurons. Nevertheless, the methylosome (PRMT5/
WDR77), a component of the signal recognition particle (SRP72), and
a stress granule marker (G3BP2) are speciﬁcally associated only with
poly-GR in both cell types according to the most stringent criteria. GO
analysis of pathways (Tyanova et al, 2016) enriched in both poly-GR
interactomes further highlights the role of cytosolic translation in
poly-GR toxicity. In patients, differential analysis of poly-GR/PR toxicity
is difﬁcult because poly-PR almost completely co-aggregates with
poly-GR (Mori et al, 2013a). Although poly-PR interactors in neurons
and HEK293 cells were distinct, GO analysis shows a clear enrichment
of splicing factors in both cell types, which is consistent with reported
effects on splicing (Kwon et al, 2014). In primary neurons, enrichment
analysis for poly-PR is additionally confounded by strong down-
regulation of many proteins including ribosomal subunits. Inter-
estingly, yeast screens also identiﬁed vastly different modiﬁers for
poly-GR and poly-PR (Jovicic et al, 2015; Chai & Gitler, 2018). Unex-
pectedly, knockout of several nonessential ribosomal subunits
rescued poly-GR toxicity in yeast, but whether this may be primarily
caused by reduced poly-GR expression was not addressed.
Poly-GR/PR interactions with stress granules and the nucleolus
None of the previous interactome studies has reported co-
aggregation of binding partners in poly-GR/PR inclusions in
patients but focused their validation efforts on the effect of poly-
GR/PR on the dynamics of membrane-less organelles, such as
stress granules and the nucleolus (Lee et al, 2016; Boeynaems et al,
2017). Here, we addressed how the interactors affect poly-GR/PR, as
phase separation could lead to aggregation of poly-GR/PR or the
interacting proteins (Shin & Brangwynne, 2017).
Previously, the interactors STAU1/2 and YBX1 have been found in
stress granules by co-localization analysis and proteomics (Thomas
et al, 2009; Somasekharan et al, 2015; Jain et al, 2016). The dsRNA-
binding proteins STAU1/2 are key components of RNA transport
granules and help to dissolve stress granules in the recovery phase
(Thomas et al, 2009), which may be impaired by binding to poly-GR/
PR. In addition, YBX1 was found to promote stress granule formation
indirectly through induction of G3BP1 translation (Somasekharan
et al, 2015). Here, we report that co-expression of STAU1/2 and YBX1
leads to formation of large cytoplasmic stress granule–like poly-
GR/PR clusters. Whether the DPR proteins are recruiting stress
granule proteins or the other way around is not clear. The poly-PR
interactor EIF4A3 was also found in stress granules but had no
effect on poly-GR/PR localization. Surprisingly, we could detect only
STAU2 but not YBX1 or classical stress granule markers (G3BP1 and
TIAR) in the poly-GR aggregates in C9orf72 patients, suggesting that
STAU2 binding may contribute to aggregation of poly-GR/PR ag-
gregates in vivo. Moreover, interaction of poly-GR/PR with stress
granule proteins may affect translation indirectly (Lee et al, 2016).
We cannot exclude that other RNA-binding proteins interacting with
poly-GR/PR contribute to the reduced translation.
Poly-GR/PR interact with several key nucleolar proteins, in-
cluding NPM1 and NOP56. Overexpression of NPM1 recruited the
predominantly cytosolic GFP-(GR)149 into the nucleolus in primary
neurons, whereas NOP56 had no such effect. Importantly, NPM1
was shown to induce phase separation of (GR)20 and (PR)20 in vitro
(Lee et al, 2016). Super-resolution microscopy shows that poly-GR/
PR speciﬁcally localize to the NPM1-positive liquid-like granular
component of the nucleolus (Lee et al, 2016). Our ﬁnding that
nucleolar poly-(GR)53 and especially poly-PR alter the distribution
of ﬁbrillarin and NOP56 within the nucleolus suggests that nu-
cleolar poly-GR/PR may interfere with ribosomal biogenesis in
vitro, which depends on NOP56 (Gautier et al, 1997). Importantly,
nucleolar localization has not been detected for any DPR species in
patients (Schludi et al, 2015; Vatsavayai et al, 2016) and the longer
GFP-(GR)149 localizing predominantly to the cytoplasm was not
acutely toxic. However, poly-GR–bearing neurons in patients have
Figure 5. Poly-GR and poly-PR co-aggregate with
ribosomal proteins in C9orf72 patients.
(A) Immunoﬂuorescent stainings of components of the
small (RPS6) and large (RPL19) ribosomal subunits in
C9orf72 patient brains and controls. Additional
ribosomal proteins are shown in Fig S4B. Note the
enrichment of ribosomal proteins in poly-GR/PR
inclusions. DAPI marks nuclei in blue. Single confocal
planes were taken. Scale bar depicts 20 μm. (B)
Quantitative analysis of co-localization of ribosomal
proteins with poly-GR aggregates (n = 3 sections with 100
poly-GR aggregates counted each from C9orf72 cortex,
mean ± SEM is shown).
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larger nucleoli (Mizielinska et al, 2017), suggesting that more subtle
nucleolar effects may be at play in patients. Investigating nucleolar
organization in patient tissues may be rewarding.
Lee et al (2016) performed epistasis experiments with a large num-
ber of poly-GR/PR interactors originally identiﬁed in HEK293 cells using
RNAi-mediated knockdown in ﬂies. Interestingly, NPM1 knockdown
reduced poly-GR toxicity in ﬂies, whereas G3BP1 knockdown strongly
enhanced poly-GR toxicity. Although they did not analyze poly-GR
localization or aggregation under these conditions, the data are con-
sistent with our hypothesis that poly-GR/PR in the nucleolus is most
toxic by inhibiting ribosomal biogenesis, whereas sequestration of
poly-GR/PR in stress granules may even be somewhat protective.
Poly-GR/PR bind ribosomes and inhibit translation
We could detect the down-regulation of ribosomal proteins in poly-
PR and to a lesser extent in GFP-(GR)149–expressing neurons (Figs 6
and S6), leading to reduced translation efﬁciency (SUnSET assay)
and an overall loss of structural proteins and cell death in poly-
PR–expressing neurons. Strikingly, the shorter GFP-(GR)53 variant,
which localized to the nucleolus, was toxic and strongly reduced
ribosome levels in neurons. The reduced levels of ribosomal
proteins and the altered organization of the nucleolus suggest that
poly-GR/PR toxicity in vitro is due to impaired ribosomal biogenesis.
However, the neuronal interactome of cytoplasmic GFP-(GR)149
strongly indicates that at least poly-GR also binds already-assembled
Figure 6. Poly-PR inhibits translation in neurons.
Primary rat cortical neurons (DIV6 + 7) were transduced with GFP, GFP-(GR)149, or
(PR)175-GFP lentivirus. (A) Immunoblots show reduced expression of several
ribosomal proteins in (PR)175-GFP–expressing neurons. Calnexin was used as
loading control. (B) Quantiﬁcation of RPS6 signal normalized to calnexin (n = 6
from three independent experiments, mean ± SEM, exact P-values: GFP versus
GFP-GR149, P = 0.1101 and GFP versus PR175-GFP, P = 0.0010 in one-way ANOVA with
Dunnett’s posttest), RPL19 signal normalized to calnexin (n = 6 from three
independent experiments, mean ± SEM, exact P-values: GFP versus GFP-GR149,
P = 0.1863 and GFP versus PR175-GFP, P = 0.0001 in the Kruskal–Wallis test with Dunn’s
posttest), and RPL36A signal normalized to calnexin (n = 6 from three independent
experiments, mean ± SEM, exact P-values: GFP versus GFP-GR149, P = 0.1487 and GFP
versus PR175-GFP, P = 0.0013 in the Kruskal–Wallis test with Dunn’s posttest). (C) To
quantify global translation, primary neurons were incubated with 1 μM puromycin
(puro) for 0, 10, and 20 min before sample preparation, which is incorporated into
truncated proteins (SUnSET system). A puromycin-speciﬁc antibody shows
reduced levels of newly synthesized proteins in poly-PR–expressing neurons.
Immunoblot for RPS6 and calnexin used as loading control. (D) Quantiﬁcation of
RPS6 signal normalized to calnexin (n = 3, mean ± SEM, Kruskal–Wallis test with
Dunn’s posttest, exact P-values: GFP versus GFP-GR149, P = 0.9999 and GFP versus
PR175-GFP, P = 0.0507) and puromycin signal normalized to calnexin (n = 6, mean ±
SEM, one-way ANOVA with Dunnett’s posttest, exact P-values: GFP versus GFP-
GR149, P = 0.2265 and GFP versus PR175-GFP, P = 0.0001).
Figure 7. Nucleolar poly-GR/PR alter nucleolar organization and inhibit
translation.
GFP, GFP-(GR)53, GFP-(GR)149, or (PR)175-GFP were transduced in primary rat
neurons. (A) Images show ﬁbrillarin immunoﬂuorescence staining of
hippocampal neurons. Left two columns represent GFP signal and ﬁbrillarin
staining in different DPR species as indicated. Right column shows merge with
additional nuclear DAPI staining in blue. Scale bar denotes 20 μm. (B) LDH
release assay detects signiﬁcant cell death on lentiviral expression of (PR)175-
GFP and GFP-(GR)53 but not GFP-(GR)149 compared with GFP control in primary
rat neurons (DIV7 + 14) (n = 3 independent experiments with six replicates each;
box plot is shown with 25th percentile, median, and 75th percentile; and
whiskers represent minimum and maximum; exact P-values: GFP versus
GFP-GR53, P = 0.0011; GFP versus GFP-GR149, P = 0.9954; and GFP versus
PR175-GFP, P = 0.0001 in one-way ANOVA with Dunnett’s posttest). (C) SUnSET
experiment in GFP-(GR)53–, GFP-(GR)149–, (PR)175-GFP–, or GFP–expressing
primary cortical neurons (DIV6+7) as in Fig 6C. Cells were incubated with 1 μM
puromycin (puro) for 10 min or not treated (nt). Note the reduced incorporation
of puromycin in neurons expressing GFP-(GR)53 and (PR)175-GFP. (D)
Quantiﬁcation of puromycin signal normalized to calnexin (n = 6 from three
independent experiments, mean ± SEM, exact P-values: GFP versus GFP-GR53,
P = 0.0022; GFP versus GFP-GR149, P = 0.8638; and GFP versus PR175-GFP, P =
0.0005 in one-way ANOVA with Dunnett’s posttest). (E) Quantiﬁcation of
ﬁbrillarin distribution within the nucleolus from (A). n = 6 to 16 images were
analyzed.
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ribosomes. Two recent proteomics studies have reported pre-
dominant interaction of (GR)20, (GR)80, and (PR)20 with cytosolic and
mitochondrial ribosomes (Kanekura et al, 2016; Lopez-Gonzalez
et al, 2016) but have not analyzed patient tissue. Here, we de-
tected robust co-localization of several ribosomal proteins with
~30% of cytoplasmic inclusions in C9orf72 patients, highlighting the
physiological signiﬁcance of the ribosomal pathway for C9orf72
pathogenesis. The next important step will be to directly show
reduced translation in a mouse model or patient tissue depending
on poly-GR/PR inclusions.
In addition, direct binding of poly-GR/PR to mRNA may inhibit
ribosomal access and thus translation (Kanekura et al, 2016), but
stronger inhibition of translation by nucleolar GFP-(GR)53 than
cytoplasmic GFP-(GR)149 argues against this hypothesis. A recent
transcriptomics study reported slightly reduced expression of
many ribosomal proteins in poly-PR–expressing neurons, con-
sistent with reduced ribosomal biogenesis (Kramer et al, 2018).
Because toxicity depends on nucleolar localization and reduction
of ribosomal proteins, we propose that poly-GR/PR mainly in-
terferes with ribosomal assembly/availability, but we cannot
exclude additional effector mechanisms because translation is
regulated at many levels. Also, the interaction of puriﬁed poly-
GR/PR and ribosomes should be analyzed in greater detail using
biophysical methods. It will be interesting to test whether re-
storing translation genetically or pharmacologically rescues
poly-PR toxicity.
Conclusion
Several hypotheses have been put forward to explain the toxicity
of arginine-rich DPR proteins in various model systems, includ-
ing impaired nucleocytoplasmic transport (Jovicic et al, 2015),
oxidative stress (Lopez-Gonzalez et al, 2016), interference with
membrane-less organelles (Lee et al, 2016; Lin et al, 2016;
Boeynaems et al, 2017), impaired splicing (Kwon et al, 2014; Lin
et al, 2016), and translation (Kanekura et al, 2016). From our
ﬁndings, using poly-GR constructs of different length, it seems
that altered nucleolar organization and impaired ribosomal
biogenesis may be the most important mechanism of acute
toxicity in vitro. Our discovery of several ribosomal proteins in
cytoplasmic DPR inclusions in patient brains suggests that
translation may be impaired by direct binding in vivo. Because
poly-GR/PR inclusions are found many years before disease
onset in a stage with moderate prodromal brain atrophy (Rohrer
et al, 2015; Vatsavayai et al, 2016), the effects are most likely less
acute than in most in vitro systems. Moreover, recruitment of
poly-GR/PR into large stress granule–like structures by over-
expression of some interactors with low-complexity domains
and detection of STAU2 in patient aggregates suggests that
phase separation may be a relevant driver of DPR aggregation. In
particular, differential expression of poly-GR/PR interactors
may, therefore, explain regional neurodegeneration despite
widespread DPR expression. Overall, trapping of ribosomes in
poly-GR/PR inclusions is the most direct link between poly-GR/
PR in vitro toxicity and patient neuropathology and suggests
a role of impaired translation in C9orf72 pathogenesis.
Materials and Methods
DNA constructs and viral packaging
Synthetic genes with alternative codons for DPR sequences (GFP-
(GR)53, GFP-(GR)149, and (PR)175-GFP) containing an ATG start codon
were subcloned into a pEF6/V5-His vector (Life Technologies) or
a lentiviral vector driven by the human synapsin promoter
(FhSynW2) (May et al, 2014). GFP from pEGFP-N1 (Clontech Labo-
ratories) was used as negative control and subcloned into the
respective vectors. Poly-GR/PR–interacting proteins were fused to
the C-terminus of tagRFP by subcloning into FU3a-tagRFP. Empty
vector was used as a control. Lentiviruses were packaged in
human embryonic kidney cells (HEK293FT; Life Technologies) as
described previously (Schwenk et al, 2014).
Cell culture, transfection, and transduction
HEK293FT cells were cultivated in DMEM with Glutamax (Life Tech-
nologies) supplemented with 10% FCS, 1% Penicillin/Streptomycin,
and 1% non-essential amino acids at 37°C with 5% CO2. Cells were
transfected with Lipofectamine 2000 (Invitrogen) following the man-
ufacturer’s instructions.
Primary cortical and hippocampal neurons were cultured from
embryonic day 19 Sprague–Dawley rats and cultivated in Neuro-
basal Medium (Life Technologies) supplemented with 2% B27
(Life Technologies), 1% Pen/Strep, and 2 mM Glutamine. Primary
neurons were transduced at 7 days in vitro (DIV7) using speciﬁed
lentiviruses.
SUnSET assay and immunoblotting
To analyze total protein synthesis, a SUnSET assay was performed.
Therefore, primary cortical neurons were treated with 10 μg/ml
puromycin (Merck) for 10 min at 37°C and 5% CO2.
For immunoblotting experiments, neurons were harvested in
2× Laemmli buffer 7 days after transduction (DIV7 + 7). Samples were
incubated at 95°C for 5 min and run on a 12% SDS–PAGE or 10%–20%
tricine gels (Novex). The following primary antibodies were used for
immunoblotting: anti-calnexin (ADI-SPA-860F; Enzo Life Technol-
ogies), anti-puromycin (clone 12D10, MABE343; Merck Millipore),
anti-RPS6 (sc-74459; Santa Cruz Biotechnology), anti-RPL19
(sc-100830; Santa Cruz Biotechnology), and anti-RPL36A (sc-100831;
Santa Cruz Biotechnology). For quantitative analysis, ImageJ was
used and statistical analysis was done using the GraphPad Prism
(version 7.01) software.
Immunostaining and imaging in cell culture
For immunostaining, cells grown on PDL-coated glass coverslips
were ﬁxed with 4% paraformaldehyde for 15 min and permeabilized
(0.2% Triton X-100 and 50 mM NH4Cl in PBS) for 5 min. After blocking
(30 min, 2% fetal bovine serum, 2% serum albumin, and 0.2% ﬁsh
gelatin in PBS), the coverslips were incubated in primary antibody
solution at RT for 1 h and washed with PBS. Finally, the cells were
incubated in Alexa-coupled secondary antibody solution and
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treated with DAPI or TO-PRO-3 for staining of the nuclei. Antibodies
and reagents used were anti-RPS6 (sc-74459; Santa Cruz Bio-
technology), anti-G3BP1 (ab181150; Abcam), anti-ﬁbrillarin (ab5821;
Abcam), DAPI (Roche Applied Science), and TO-PRO-3 (Thermo
Fisher Scientiﬁc). Single-plane images were obtained on a confocal
laser scanning LSM710 microscope (Carl Zeiss) with a 63× or 40×
immersion objective. Image editing and particle analysis was carried
out using ImageJ software, and for statistical analysis, GraphPad
Prism (version 7.01) software was used.
Patient samples and immunoﬂuorescence patient stainings
All patient materials were provided by the Neurobiobank Munich,
Ludwig Maximilians University of Munich. Parafﬁn-embedded brain
sections were deparafﬁnated and rehydrated with xylene and
ethanol. To retrieve the antigen, slides were boiled 4× for 5 min in
100mM citrate buffer of pH 6.0 using a microwave. After a brief rinse
with deionized water, the sections were washed in PBS/0.05%
Brij35, followed by blocking with 2% fetal calf serum in PBS for
5 min. The tissue was incubated overnight at 4°C in primary antibody
solution. The following antibodies were used: STAU2 (ab60724;
Abcam), anti-YBX1 (ab12148; Abcam), anti-FMRP (ab17722; Abcam),
anti-G3BP2 (ab86135; Abcam), anti-TIAR (sc-136266; Santa Cruz
Biotechnology), anti-RPS6 (sc-74459; Santa Cruz Biotechnology),
anti-RPL19 (sc-100830; Santa Cruz Biotechnology), anti-RPS25
(HPA031801; Atlas Antibodies), anti-RPL36A (sc-100831; Santa Cruz
Biotechnology), anti-GTPBP4 (ab184124; Abcam), anti-NOP56
(HPA049918; Atlas Antibodies), anti-PRMT1 (ab73246; Abcam), anti-
WDR77 (HPA027271; Atlas Antibodies), anti-MAGOHB (ab186431;
Abcam), anti-TRA2A (ab72625; Abcam), anti-GR clone 7H1 detecting
predominantly non-methylated and asymmetrically dimethylated
poly-GR (Schludi et al, 2015), anti-PR clone 32B3 raised against non-
methylated poly-PR (Schludi et al, 2015), and rabbit polyclonal (Mori
et al, 2013a). Afterward, sections were washed twice in PBS/0.05%
Brij35 before incubation with Alexa-coupled secondary antibodies
for 1 h at RT. Next, the sections were washed again, treated with DAPI
for 15 min, and washed twice in PBS/0.05% Brij35 and twice in PBS
only. The tissue was incubated in Sudan Black for 1 min at RT, rinsed
in PBS, and mounted with Fluoromount Aqueous Mounting Medium
(Merck).
Antibodies for poly-GR/PR that did not show convincing staining
in brain sections were anti-CCDC40 (ab121727; Abcam), anti-PABPC4
(ab101492; Abcam), anti-MRPS9 (ab187906; Abcam), anti-MRPS11
(HPA050345; Atlas Antibodies), anti-MRPS23 (ab154533; Abcam),
anti-MRPL12 (ab58334; Abcam), anti-PRMT5 (ab31751; Abcam), anti-
CAPZA (ab166892; Abcam), anti-MOV10 (ab60132; Abcam), anti-ODZ3
(ab198923; Abcam), anti-SH3KBP (ab151574; Abcam), anti-TRA2B
(ab66901; Abcam), anti-NDUFS3 (ab110246; Abcam), anti-SRP72 (PA5-
56994; Thermo Fisher Scientiﬁc), anti-SNRPD3 (ab121129; Abcam), and
anti-SNRPD2 (PA5-27547; Invitrogen).
Viability of primary neurons and HEK293FT cells
Toxicity assays in transduced primary cortical neurons (DIV7 + 14)
and HEK293FT cells were performed in 96-well plates using the LDH
Cytotox Non-Radioactive Cytotoxicity Assay (Promega) following the
manufacturer’s instructions. To assess cell viability in HEK293FT cells,
an XTT (Roche) assay was used according to the manufacturer’s
protocols. Cells were cultivated in a 96-well plate. Absorption was
measured after 24-h incubation time. Statistical analysis was per-
formed using GraphPad Prism (version 7.01) software.
Immunoprecipitation of poly-GR and poly-PR aggregates
in neurons and HEK293FT
Quadruplicates of GFP-(GR)149–, (PR)175-GFP–, or GFP-infected cor-
tical neurons (DIV7 + 8) and transfected HEK293FT cells were
harvested in Benzonase Nuclease (Sigma) containing lysis buffer
(2% Triton X-100, 750 mM NaCl, and 1 mM KH2PO4). Cell lysates were
rotated for 45 min at 4°C. 10% was kept for whole proteome
analysis, whereas the remaining samples were centrifuged at 1,000 g
for 5 min at 4°C. With GFP antibody (clone N86/38; Neuromab),
preincubated Protein G Dynabeads (Life Technologies) were added
to the rest of the supernatant and incubated for 3 h at 4°C. After
three washing steps (in 150 mM NaCl, 50 mM Tris, pH 7.5, and 5%
Glycerol), they were used for further sample preparation for mass
spectrometry analysis.
LC-MS/MS
Peptides were separated on an EASY-nLC 1000 HPLC system
(Thermo Fisher Scientiﬁc) via in-house packed columns (75-μm
inner diameter, 30-cm length, and 1.9-μm C18 particles [Dr. Maisch
GmbH]) in a gradient of buffer A (0.5% formic acid in H2O) to buffer B
(0.5% formic acid in H2O and 80% acetonitrile) at 300 nl/min ﬂow
rate. For IPs, we increased the content of buffer B from 2% to 30%
85 min before increasing the concentration of buffer B to 95% to
wash the column. For complete proteomes, we increased the
content of buffer B from 5% to 30% 155 min before increasing the
concentration of buffer B to 95% to wash the column. The column
temperature was set to 60°C. A Quadrupole Orbitrap mass spec-
trometer (Scheltema et al, 2014) (Q Exactive HF; Thermo Fisher
Scientiﬁc) was directly coupled to the LC via nano-electrospray
source. The Q Exactive HF was operated in a data-dependent mode.
The survey scan range was set from 300 to 1,650 m/z, with a res-
olution of 60,000 at m/z 200. Up to the 15 most abundant isotope
patterns with a charge greater than or equal to two were subjected
to collision-induced dissociation fragmentation at a normalized
collision energy of 27, an isolation window of 1.4 Th, and a resolution
of 15,000 at m/z 200. Dynamic exclusion to minimize resequencing
was set to 30 s (proteome) or 20 s (IP). Data were acquired using
Xcalibur software (Thermo Fisher Scientiﬁc).
MS data analysis and statistics
To process MS raw ﬁles, we employed the MaxQuant software
(v 1.5.3.54 for HEK data and 1.5.4.3 for neuron data) (Cox &Mann, 2008)
and Andromeda search engine (Cox et al, 2011), against the Uni-
ProtKB rat FASTA database (08/2015) and UniProtKB human FASTA
database (08/2015), respectively, using default settings. Enzyme
speciﬁcity was set to trypsin, allowing cleavage N-terminally to
proline and up to two mis-cleavages. Carbamidomethylation was
set as ﬁxed modiﬁcation, and acetylation (N terminus) and me-
thionine oxidation were set as variable modiﬁcations. A false
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discovery rate (FDR) cutoff of 1% was applied at the peptide and
protein level. For rat neuron data, the FDR was independently
calculated and applied for IP samples and complete proteomes by
setting individual parameter groups in MaxQuant. “Match between
runs,” which allows the transfer of peptide identiﬁcations in the
absence of sequencing after nonlinear retention time alignment,
was enabled with a maximum retention time window of 0.7 min.
Protein identiﬁcation required at least one razor peptide. Data were
ﬁltered for common contaminants (n = 247). Peptides only identiﬁed
by site modiﬁcation were excluded from further analysis. Proteins
were normalized with MaxLFQ label-free normalization (Cox et al,
2014). The mass spectrometry proteomics data have been deposited
to the ProteomeXchange Consortium via the PRIDE partner repository
with the dataset identiﬁer PXD008691 (Vizcaino et al, 2016).
For bioinformatic analysis and visualization, we used the open
PERSEUS (v 1.5.2.12, 1.5.3.4, 1.5.4.2, 1.5.5.5, and 1.5.8.7) environment
(Tyanova et al, 2016), MaxQuant (neurons: 1.5.4.3 and HEK: 1.5.3.54),
and the R framework (Team, R Development Core, 2008). Imputation
ofmissing values was performedwith a normal distribution (width =
0.3 and shift = 1.8). For pairwise comparison of proteomes and
determination of signiﬁcant differences in protein abundances,
t test statistics were applied with a permutation-based FDR of 5%
and S0 of 1 (Tusher et al, 2001), requiring at least 66% valid values in
at least one group per comparison. For the 1D and 2D annotation,
we ﬁrst matched GO data (GOMF name, GOCC name, GOCC slim
name, GOBP slim name, and Kegg and UniProt keywords) to the
protein identiﬁers (major ID) in Perseus. Moreover, the annotation
for stress granule proteins identiﬁed by Jain et al (2016) for humans
was assigned both for HEK and rat neuron data. Stress granule
annotations were transferred from human to rat for genes with
identical gene names in both species. The 1D and 2D annota-
tion enrichment was performed on the Welch’s t test difference in
the Perseus environment. FDR control was performed using the
Benjamini–Hochberg correction separately within each annotation
category, e.g., GOCC or GOBP. Accordingly, the FDR cutoff (q-value <
5%) relates to slightly different P-values in the different annotation
categories, thereby leading to signiﬁcant (black) and insigniﬁcant
(gray) populations slightly overlapping in the –log10 (P-value) di-
mension in the 1D annotation plots (Fig S6B). The 2D annotation
plots show annotation terms with q-values < 0.1. Both 1D and 2D
annotation terms were ﬁltered for terms comprising at least six
proteins quantiﬁed by mass spectrometry.
We assessed the content of low complexity in the neuronal
interactome based on IUPred-L (Dosztanyi et al, 2005). We queried
all proteins detected in the neuronal interactome data (see ﬁltering
criteria), signiﬁcant poly-PR interactors, and signiﬁcant poly-GR
interactors in D2P2 (Oates et al, 2013). Queries were based on
MaxQuant reported UniProt identiﬁer, using the ﬁrst entry if
multiple identiﬁers were reported in protein groups. For deter-
mining signiﬁcant differences, we employed the Mann–Whitney–
Wilcoxon test.
Supplementary Information
Supplementary Information is available at https://doi.org/10.26508/lsa.
201800070.
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